Volitinib in Treating Patients With Recurrent or Refractory Primary CNS Tumors
ACTIVE_NOT_RECRUITING
Status
Conditions
- Recurrent Diffuse Intrinsic Pontine Glioma
- Recurrent Malignant Glioma
- Recurrent Medulloblastoma
- Recurrent Primary Central Nervous System Neoplasm
- Refractory Diffuse Intrinsic Pontine Glioma
- Refractory Malignant Glioma
- Refractory Medulloblastoma
- Refractory Primary Central Nervous System Neoplasm
Interventions
- PROCEDURE: Biospecimen Collection
- PROCEDURE: Magnetic Resonance Imaging
- DRUG: Savolitinib
- PROCEDURE: X-Ray Imaging
Sponsor
National Cancer Institute (NCI)